France and Germany alone on pioglitazone suspensions for now
This article was originally published in Scrip
Executive Summary
So far, no other regulatory agencies besides those in France and Germany have moved to halt new prescriptions of products containing pioglitazone, the oral antidiabetic's manufacturer has told Scrip.